Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission

Joan How; Kiran R. Vij; Maryam Ebadi; Todd E. DeFor; Rizwan Romee; Michelle M. Dolan; Celalettin Ustun; Daniel J. Weisdorf; Michael A. Linden; Armin Rashidi

doi:10.1002/ajh.25262

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission

Joan How, Kiran R. Vij, Maryam Ebadi, Todd E. DeFor, Rizwan Romee, Michelle M. Dolan, Celalettin Ustun, Daniel J. Weisdorf, Michael A. Linden, Armin Rashidi

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	E381-E383
Journal	American Journal of Hematology
Volume	93
Issue number	12
DOIs	https://doi.org/10.1002/ajh.25262
State	Published - Dec 2018

Bibliographical note

Funding Information:
Research reported in this publication was supported by National Institutes of Health grant P30 CA77598 utilizing the Biostatistics and Bioin-formatics Core shared resource of the Masonic Cancer Center, University of Minnesota and by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1002/ajh.25262

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239215

OpenUrl availability

Full text

Cite this

How, J., Vij, K. R., Ebadi, M., DeFor, T. E., Romee, R., Dolan, M. M., Ustun, C., Weisdorf, D. J., Linden, M. A., & Rashidi, A. (2018). Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. American Journal of Hematology, 93(12), E381-E383. https://doi.org/10.1002/ajh.25262

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. / How, Joan; Vij, Kiran R.; Ebadi, Maryam et al.
In: American Journal of Hematology, Vol. 93, No. 12, 12.2018, p. E381-E383.

Research output: Contribution to journal › Letter › peer-review

How, J, Vij, KR, Ebadi, M, DeFor, TE, Romee, R, Dolan, MM, Ustun, C, Weisdorf, DJ , Linden, MA & Rashidi, A 2018, 'Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission', American Journal of Hematology, vol. 93, no. 12, pp. E381-E383. https://doi.org/10.1002/ajh.25262

@article{7edc864052ea4bcf89fb45f79fd8a726,

title = "Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission",

author = "Joan How and Vij, {Kiran R.} and Maryam Ebadi and DeFor, {Todd E.} and Rizwan Romee and Dolan, {Michelle M.} and Celalettin Ustun and Weisdorf, {Daniel J.} and Linden, {Michael A.} and Armin Rashidi",

note = "Funding Information: Research reported in this publication was supported by National Institutes of Health grant P30 CA77598 utilizing the Biostatistics and Bioin-formatics Core shared resource of the Masonic Cancer Center, University of Minnesota and by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",

year = "2018",

month = dec,

doi = "10.1002/ajh.25262",

language = "English (US)",

volume = "93",

pages = "E381--E383",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "12",

}

TY - JOUR

T1 - Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission

AU - How, Joan

AU - Vij, Kiran R.

AU - Ebadi, Maryam

AU - DeFor, Todd E.

AU - Romee, Rizwan

AU - Dolan, Michelle M.

AU - Ustun, Celalettin

AU - Weisdorf, Daniel J.

AU - Linden, Michael A.

AU - Rashidi, Armin

N1 - Funding Information: Research reported in this publication was supported by National Institutes of Health grant P30 CA77598 utilizing the Biostatistics and Bioin-formatics Core shared resource of the Masonic Cancer Center, University of Minnesota and by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85054563005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054563005&partnerID=8YFLogxK

U2 - 10.1002/ajh.25262

DO - 10.1002/ajh.25262

M3 - Letter

C2 - 30144151

AN - SCOPUS:85054563005

SN - 0361-8609

VL - 93

SP - E381-E383

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 12

ER -

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this